RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Ironshore Pharmaceuticals Inc. (“Ironshore”), a wholly owned subsidiary of Highland Therapeutics Inc. and a leader in the commercialization of novel ...

Consequently, the FDA reclassified Mallinckrodt’s abbreviated New Drug Application (ANDA) 202608 for methylphenidate ER tablets with dosage strengths of 27 mg, 36 mg and 54 mg from AB (freely ...

Methylphenidate hydrochloride extended-release tablets should be given cautiously to patients with a history of drug dependence or alcoholism. Chronic abusive use can lead to marked tolerance and ...

Extended-Release Is Now Chewable: First and Only Long-Acting Chewable Methylphenidate Treatment for Attention Deficit Hyperactivity Disorder (ADHD) in patients ages 6 years old and above Monday, ...

ALPHARETTA, Ga., Aug. 19, 2025 /PRNewswire/ -- Alora Pharmaceuticals, LLC, the parent company of Vertical Pharmaceuticals, LLC, a leading pharmaceutical company committed to advancing access to ...

STAMFORD, Conn.--(BUSINESS WIRE)--Adlon Therapeutics L.P., a subsidiary of Purdue Pharma L.P., announced that the U.S. Food and Drug Administration (FDA) approved a supplemental New Drug Application ...

The Food and Drug Administration (FDA) has expressed concerns about the therapeutic equivalence of two generic versions of Concerta (methylphenidate HCl extended-release; Janssen) tablets indicated ...

(RTTNews) - Dr. Reddy's Laboratories Ltd. (RDY), an integrated pharmaceutical company, announced the launch of Methylphenidate Hydrochloride Extended-Release Tablets USP, 18 mg, 27 mg, 36 mg and 54 mg ...

A medication used to treat attention deficit/hyperactivity disorder (ADHD) and narcolepsy carries the FDA’s most serious warning, but got recalled for another reason: metal was found embedded in a ...

Credit: Alora Pharmaceuticals. Relexxii (methylphenidate hydrochloride extended-release tablets) is now available for the treatment of ADHD in adults and pediatric patients. Relexxii ® ...

We apologize, but this video has failed to load. JORNAY PM is the only stimulant medication that is dosed in the evening and has demonstrated improvement in the severity of ADHD symptoms in the early ...

Adlon Therapeutics L.P., a subsidiary of Purdue Pharma L.P., announced two recent online publications of studies related to the efficacy, safety and pharmacokinetics of Adhansia XR® (methylphenidate ...